报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -5.62% | -11447.88% | -1378.21% | 133/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -0.38% | -114.62% | -231.03% | 117/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 0.29% | -69.47% | -65.48% | 112/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 0.84% | 112.73% | 1596.97% | 99/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 0.05% | -95.24% | -98.1% | 119/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 2.6% | 198.85% | 173.68% | 74/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 0.95% | 13.1% | 114.39% | 96/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | -6.6% | 43.3% | -734.62% | 123/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 1.04% | -68.96% | 19.54% | 104/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 0.87% | -55.15% | 3.57% | 107/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 0.84% | -45.1% | 107.22% | 99/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | -11.64% | -216.28% | -447.46% | 134/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 3.35% | -46.99% | 72.68% | 94/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 1.94% | -63.81% | 26.8% | 99/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 1.53% | -79.95% | -84.72% | 78/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 10.01% | -68.2% | 58.39% | 54/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | 6.32% | 2% | 17.91% | 64/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-06-30 | 5.36% | -60.3% | -29.75% | 50/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
2020-03-31 | 7.63% | 2% | -75.76% | 7/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
2019-12-31 | 31.48% | 36.22% | 133.19% | 3/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
2019-06-30 | 13.5% | 2% | -41.58% | 5/160 | 5.05% | 奥赛康 | 35% | 行业排名> |
2018-12-31 | 23.11% | 76.82% | 76.82% | 8/160 | 7.09% | 奥赛康 | 28.15% | 行业排名> |
2017-12-31 | 13.07% | -84% | -84% | 30/160 | 9.66% | 宏源药业 | 21.91% | 行业排名> |
2016-12-31 | 81.7% | 2% | 2% | 1/160 | 6.33% | 奥赛康 | 9.7% | 行业排名> |